Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome.
about
Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data.Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort studyInvestigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome.Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic reviewAssociation of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement.Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UKDerivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis.Computerised Pill Counting--how will technology support research into medication adherence?Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes.A systematic review to assess adherence and persistence with statins.Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention.Research and Education.Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study.Impact of Bubble Packaging on Adherence to Long-Term Oral Medications Used to Prevent Cardiovascular Disease.Persistence, Adherence and Outcomes with Antiplatelet Regimens following Cerebral Infarction in the Tayside Stroke Cohort
P2860
Q30248710-90E43F36-65EB-4FD6-9D27-7BABFE9D4327Q31049583-4E49C8B7-8685-4B63-9C63-14C3F4A4100FQ33582496-71689225-3691-472E-9760-F98AEAF28BE2Q33588629-7A50F031-35A7-4A18-A43E-63B47F692736Q34554376-4EACF7DA-8584-413F-B46C-548A0C198170Q34772182-A62803FD-23F2-4CDD-9D5E-003E2CE48B4CQ35675611-A2A8AC79-D26E-4A9C-87D0-74D8DA32E2D2Q35840753-5F9F508D-98F7-42FC-A87C-B124315E27CDQ36792716-7161597E-4D93-4FD5-94EC-55567813A87EQ37289807-81060347-6925-4364-8BAC-23494D3D4CE0Q38372155-09DF50E2-9AB4-479C-A30D-F3C8733D15CAQ39026831-28B02DDC-60BD-47E7-8827-6CE8B8EED40CQ39746156-4B96556D-E9B3-4E8B-82B3-B4BD04D8476AQ45762885-18EEBB32-018B-428D-BFEF-E0194588D600Q46370506-E5B9F8C3-46BA-4B35-9D46-632BFF74B0CAQ55178590-E2EDEC36-354B-4A4E-A45B-B2294EA90779Q57403260-55318C3B-8FAA-412D-8458-B29D83BACE78
P2860
Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Adherence to statin or aspirin ...... 10-year follow-up of outcome.
@ast
Adherence to statin or aspirin ...... 10-year follow-up of outcome.
@en
type
label
Adherence to statin or aspirin ...... 10-year follow-up of outcome.
@ast
Adherence to statin or aspirin ...... 10-year follow-up of outcome.
@en
prefLabel
Adherence to statin or aspirin ...... 10-year follow-up of outcome.
@ast
Adherence to statin or aspirin ...... 10-year follow-up of outcome.
@en
P2860
P1476
Adherence to statin or aspirin ...... 10-year follow-up of outcome.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.2008.03212.X
P407
P577
2008-07-01T00:00:00Z